We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




MRS May Have Antidepressant Effect

By HospiMedica staff writers
Posted on 23 Mar 2005
Using high-speed echo planar magnetic resonance spectroscopic (EP-MRS) imaging has produced antidepressant effects in rats, validating similar observations made in humans, according to a new study.

These findings suggest that electromagnetic fields produced by this imaging method may alter brain biology, according to researchers at Harvard Medical School (Boston, MA, USA) and McLean Hospital (Belmont, MA, USA). More...
They discovered the same effects in the laboratory rats as seen after administering conventional antidepressant drugs.

The investigators observed this effect after another group of researchers at McLean Hospital noted that EP-MRS have improved the moods of humans in the depressed stage of bipolar disorder. This new study, published in the March 15, 2005, issue of the journal Biological Psychiatry, was devised to see if this antidepressant reaction to this imaging modality worked in animal models similar to that observed in the humans with bipolar disorder.

When the rats were put through a series of tests to stress them, they developed helpless behavior, which may be their adaptation for despair, according to the investigators. In the study, the rats who had been imaged with EP-MRS demonstrated less helplessness during the stress testing, similar to the effects seen with antidepressant agents such as desipramine and fluoxetine.

While this may provide a new way to treat depressive disorders, the study also suggests that some kinds of MRI scanning are more invasive than previously believed. They suggest caution when high-speed MRI is utilized to detect or assess brain disorders. There are still effects from being exposed to electrical and magnetic fields from this kind of imaging that researchers do not yet totally understand.




Related Links:
Harvard Medical School

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.